in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Lonza to Buy Stake in Indian Firm?
6:29 AM MDT | March 24, 2010 | Deepti Ramesh
Lonza is in discussions with pharmaceutical company Aptuit Laurus (Hyderabad, India), to acquire a majority stake in the Indian company, say press reports. The deal maybe valued at about Rs.3.5 billion-Rs.4.5 billion ($77 million-$99 million), reports add. Aptuit Laurus mainly produces active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals, and the company also provides various services including early-stage drug discovery, medicinal chemistry, drug product development and analytical services. Aptuit Laurus was formed in 2007 as a joint...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee